Business Description
Par Drugs and Chemicals Ltd
ISIN : INE04LG01015
Total Employee Number:
121Compare
Compare
Traded in other countries / regions
PAR.India IPO Date
2019-05-16Description
Par Drugs and Chemicals Ltd manufactures active Pharmaceutical Ingredients (APIs) and fine chemicals, serving domestic and international markets. Specializing in essential magnesium-based compounds and other specialty chemicals such as Magnesium Hydroxide, Magnesium Trisilicate, Magnesium Carbonate, various grades of Magnesium Oxide, Dried Aluminum Hydroxide Gel, and Sucralfate USP, the Company produces high-quality bulk drugs used in the formulation of finished pharmaceutical products like tablets, capsules, and liquids. Committed to maintaining stringent quality standards and utilizing manufacturing processes, the Company plays a vital role in supplying reliable ingredients that ensure the safety, efficacy, and stability of pharmaceutical formulations internationally.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.87 | |||||
Interest Coverage | 105.4 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.6 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.9 | |||||
3-Year EBITDA Growth Rate | 4.9 | |||||
3-Year EPS without NRI Growth Rate | 5.3 | |||||
3-Year FCF Growth Rate | 36.1 | |||||
3-Year Book Growth Rate | 16.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.03 | |||||
9-Day RSI | 52.92 | |||||
14-Day RSI | 52.1 | |||||
3-1 Month Momentum % | 0.74 | |||||
6-1 Month Momentum % | -9.31 | |||||
12-1 Month Momentum % | -5.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.68 | |||||
Quick Ratio | 4.29 | |||||
Cash Ratio | 3.04 | |||||
Days Inventory | 47.02 | |||||
Days Sales Outstanding | 54.43 | |||||
Days Payable | 80.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.17 | |||||
Operating Margin % | 12.95 | |||||
Net Margin % | 12.65 | |||||
EBITDA Margin % | 20.39 | |||||
FCF Margin % | 13.96 | |||||
OCF Margin % | 15.85 | |||||
ROE % | 12.39 | |||||
ROA % | 10.46 | |||||
ROIC % | 12.05 | |||||
3-Year ROIIC % | -3.6 | |||||
ROC (Joel Greenblatt) % | 32.36 | |||||
ROCE % | 15.12 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 8.59 | |||||
PE Ratio without NRI | 8.59 | |||||
Shiller PE Ratio | 11.68 | |||||
Price-to-Owner-Earnings | 7.3 | |||||
PEG Ratio | 1.59 | |||||
PS Ratio | 1.09 | |||||
PB Ratio | 1.01 | |||||
Price-to-Tangible-Book | 1.01 | |||||
Price-to-Free-Cash-Flow | 7.79 | |||||
Price-to-Operating-Cash-Flow | 6.84 | |||||
EV-to-EBIT | 4.06 | |||||
EV-to-EBITDA | 3.35 | |||||
EV-to-Revenue | 0.68 | |||||
EV-to-FCF | 4.82 | |||||
Price-to-GF-Value | 0.44 | |||||
Price-to-Projected-FCF | 0.49 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.83 | |||||
Price-to-Graham-Number | 0.62 | |||||
| Price-to-Net-Current-Asset-Value | 2.4 | |||||
| Price-to-Net-Cash | 4.6 | |||||
Earnings Yield (Greenblatt) % | 24.65 | |||||
FCF Yield % | 12.86 | |||||
Forward Rate of Return (Yacktman) % | 14.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Par Drugs and Chemicals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,036.556 | ||
| EPS (TTM) (₹) | 10.65 | ||
| Beta | 0.927 | ||
| 3-Year Sharpe Ratio | -0.42 | ||
| 3-Year Sortino Ratio | -0.52 | ||
| Volatility % | 36.86 | ||
| 14-Day RSI | 52.1 | ||
| 14-Day ATR (₹) | 3.71963 | ||
| 20-Day SMA (₹) | 91.0985 | ||
| 12-1 Month Momentum % | -5.63 | ||
| 52-Week Range (₹) | 78.05 - 122.43 | ||
| Shares Outstanding (Mil) | 12.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Par Drugs and Chemicals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Par Drugs and Chemicals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 2:1 Stock Split | 2021-04-27 | 61.60 (+0.24%) |
Show
Entries
Par Drugs and Chemicals Ltd Frequently Asked Questions
What is Par Drugs and Chemicals Ltd(NSE:PAR)'s stock price today?
The current price of NSE:PAR is ₹90.49. The 52 week high of NSE:PAR is ₹122.43 and 52 week low is ₹78.05.
When is next earnings date of Par Drugs and Chemicals Ltd(NSE:PAR)?
The next earnings date of Par Drugs and Chemicals Ltd(NSE:PAR) is .
Does Par Drugs and Chemicals Ltd(NSE:PAR) pay dividends? If so, how much?
Par Drugs and Chemicals Ltd(NSE:PAR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Par Drugs and Chemicals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers